Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Ampio Pharmaceuticals, Inc. | v461079_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Ampio Pharmaceuticals, Inc. | v461079_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Ampio Pharmaceuticals, Inc. | v461079_ex31-1.htm |
| 10-K - 10-K - Ampio Pharmaceuticals, Inc. | v461079_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Ampio Pharmaceuticals, Inc.’s Registration Statements on Form S-8 (File Nos. 333-186077, 333-181626, 333-175161, and 333-194428) and Form S-3 (File No. 333-193096) of our report dated March 16, 2017, relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Annual Report on Form 10-K.
/s/ EKS&H LLLP
March 16, 2017
Denver, Colorado